Farms.com Home   News

CASE Announces Approval of B20 Biodiesel for All G Series Wheel Loaders

FPT Industrial announced today at the National Biodiesel Conference & Expo that it has approved B20 biodiesel for use in its NEF4, NEF 6 and CURSOR Tier 4 Final diesel engines. This announcement makes all CASE Construction Equipment G Series wheel loaders approved for use with B20 biodiesel directly from the factory.

Wheel loaders in these size classes are used extensively in construction, public works, road and bridge construction, concrete and asphalt production, aggregates and agriculture. The announcement comes after extensive testing by FPT where it was confirmed that these engines performed comparably to the same engines powered by off-road diesel. The study highlighted no adverse effects to the engines. This approval is inclusive of the NEF 4 (4.5L), NEF 6 (6.7L) and CURSOR (8.7L) diesel engines already featured in CASE G Series wheel loaders.  

“The push for renewable resources and reducing the carbon footprint of heavy equipment will include many technologies and approaches — biodiesel is one of the fastest and most efficient ways that we can benefit from renewable energy today,” says Terry Dolan, vice president – North America, CASE Construction Equipment. “FPT has long been at the forefront of off-road diesel engine technology built to lower emissions and reduce the carbon footprint — and the fact that our diesel equipment that already features these engines can help contractors, municipalities and farms better achieve their renewable goals is a massive step forward.”  

B20 biodiesel is the most prevalent blend of biodiesel available in North America. Even with this announcement, it is important that all owners of construction equipment consult with their dealer and the warranty of their equipment before using biodiesel in their machines.

This is the second major renewable energy announcement from CASE for commercially available equipment — who delivered the first electric backhoe loaders to customers in 2021.

Source : Case IH

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.